• Clinical Trial Tech – What Investors Want And Studies Need

    Feb 20 | Clinical Research News | The perspectives of clinical trial technology investors and trends for future investment were the topics of a pair of fast-paced panel discussions at last week’s Summit for Clinical Ops Professionals (SCOPE) in Orlando. What investors want appears to be well aligned with what sponsors and sites say they need—solutions running the gamut from better matching patients to trials and improving access to streamlining the way studies get designed and conducted. More
  • SCOPE Summit 2024 Award Winners

    Feb 15 | Clinical Research News | SCOPE Summit 2024 once again shined a spotlight on the breakthroughs, discoveries, and achievements of hundreds of organizations in their efforts to improve clinical trials and help patients worldwide. Three awards were presented at the conference: the Participant Engagement Award, the Site Innovation Award, and the Best of Show Award. More
  • Pharmaceutical Targets Identified For Osteoarthritis

    Feb 13 | Clinical Research News | Researchers from the University of Adelaide (Australia) and the Columbia University (New York) have “reimagined” osteoarthritis, providing a pharmaceutical target for the discovery of drugs to reverse and treat the ubiquitous degenerative joint disease. Osteoarthritis was originally believed to be a “wear and tear” condition, and some people still refer to it that way, which wrongly implies that its progression is a matter of time and inevitable. More
  • New Products, Company News On Display at SCOPE

    Feb 12 | Clinical Research News | The days leading up to the Summit for Clinical Ops Professionals—SCOPE—are a busy time for the clinical trials and clinical research space. The event kicked off yesterday and so far we’ve gathered these company and product news. More
  • New Patient Scoring Method To Enable Precision Medicine For Chronic Diseases

    Feb 08 | Clinical Research News | In a big advance for precision medicine, researchers in Australia have developed a genetic biomarker of people’s response to sodium reduction. It is often but not always the case that modifying sodium levels lowers blood pressure by reducing the fluid volume of blood in the cardiovascular system, and knowing in advance how patients will respond could help eliminate the “treatment odyssey” that many of them are experiencing. More
  • Best of Show Finalists Named for SCOPE 2024

    Feb 07 | Clinical Research News | Dozens of companies are showcasing new products at next week’s Summit for Clinical Ops Executives, and 37 have been named finalists in the Best of Show People’s Choice Awards. The SCOPE community is invited to identify exceptional innovation in technologies used by life science professionals, voting on the most impactful new products of the year. Winners will be announced at the event on Tuesday, February 13. More
  • Two-In-One Cholesterol-Lowering Vaccine Now Ready For Clinical Testing

    Feb 06 | Clinical Research News | Investigators with The University of New Mexico (UNM) and the National Institutes of Health (NIH) have succeeded in developing a cholesterol-lowering vaccine that works independently of statins. It could become the next vaccine-based approach targeting PCSK9 (proprotein convertase subtilisin/kexin type 9 serine protease) to enter clinical trials. More
  • Greenphire Acquires Clincierge

    Feb 02 | Clinical Research News | Yesterday, Greenphire, an innovator in clinical trials software, announced the acquisition of Clincierge, a premier provider of concierge travel and logistics support for patients participating in clinical trials. More
  • Smartwatch Could Reduce Fallout From False-Positive AFib Readouts

    Feb 01 | Clinical Research News | A clinical-grade smartwatch does a good job of detecting possible atrial fibrillation (AFib), which could fill the need for a noninvasive option for monitoring patients for more than 30 days. Current available electrocardiography (ECG) technologies, such as Holter monitors and wearable event recorders, are both more time-limited and resource-intensive. More
  • Illumina Ventures Labs Now Operational, Personalized Medicine Coalition Releases 2024 Plans, Imagine Pharma Forms the Imagine Pharma Foundation, Collaborations, More

    Jan 31 | Diagnostics World | Illumina Ventures Labs is now operational and finalizing agreements with several startup companies; the Personalized Medicine Coalition has released their Strategic Plan for Advancing Personalized Medicine in 2024; Imagine Pharma announced the formation of The Imagine Pharma Foundation, a private not for profit charitable organization dedicated to advancing metabolic research to significantly impact the lives of those affected by diabetes, with a particular emphasis on serving veterans; several collaborations and partnerships have been formed to tackle trials, studies, and research; more. More
View more articles
 
DXX-Industry-spotlight
SOT

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.